Kovitz Investment Group Partners’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,049
Closed -$538K 448
2021
Q1
$538K Sell
3,049
-600
-16% -$106K 0.01% 336
2020
Q4
$639K Hold
3,649
0.02% 319
2020
Q3
$628K Hold
3,649
0.02% 306
2020
Q2
$448K Buy
+3,649
New +$423K 0.01% 314
2020
Q1
Sell
-2,849
Closed -$405K 407
2019
Q4
$405K Buy
2,849
+12
+0.4% +$1.53K 0.01% 332
2019
Q3
$338K Sell
2,837
-163
-5% -$19.4K 0.01% 335
2019
Q2
$408K Sell
3,000
-1,425
-32% -$190K 0.01% 316
2019
Q1
$627K Sell
4,425
-2,075
-32% -$272K 0.02% 308
2018
Q4
$737K Sell
6,500
-950
-13% -$109K 0.03% 212
2018
Q3
$834K Hold
7,450
0.04% 100
2018
Q2
$847K Sell
7,450
-1,350
-15% -$162K 0.04% 98
2018
Q1
$1.08M Hold
8,800
0.05% 88
2017
Q4
$978 Sell
8,800
-3,750
-30% -$403K 0.04% 93
2017
Q3
$1.26M Hold
12,550
0.06% 79
2017
Q2
$1.29M Buy
+12,550
New +$1.21M 0.07% 77

Other funds holding VAR

Kovitz Investment Group Partners's VAR Position: Q2 2021 in Review

Kovitz Investment Group Partners sold out of Varian Medical Systems, Inc. (VAR) in Q2 2021, closing a stake of 3,049 shares — an estimated $538K sold.

Kovitz Investment Group Partners first reported a position in VAR in Q2 2017 and held it in 15 quarters. The position peaked at $1.29M in Q2 2017. 1 fund tracked by Wall St. Rank holds VAR as of Q2 2021.

  • Kovitz Investment Group Partners reported no remaining Varian Medical Systems, Inc. position as of Q2 2021 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 3,049 Varian Medical Systems, Inc. shares in Q2 2021, an estimated $538K.
  • Kovitz Investment Group Partners first reported a position in Varian Medical Systems, Inc. in Q2 2017 and held it in 15 quarters.
  • Kovitz Investment Group Partners's Varian Medical Systems, Inc. position peaked at $1.29M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2021.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2021, filed 30 Jul 2021.